Literature DB >> 10915595

Expression of the human poliovirus receptor/CD155 gene during development of the central nervous system: implications for the pathogenesis of poliomyelitis.

M Gromeier1, D Solecki, D D Patel, E Wimmer.   

Abstract

The gene for the human poliovirus receptor (hPVR/CD155) is the founding member of a new family of genes encoding proteins belonging to the immunoglobulin superfamily. To determine whether CD155 is expressed during mammalian development, we have made use of the previously characterized promoter of the CD155 gene and generated mice transgenic for a CD155 promoter-driven beta-galactosidase reporter gene. Expression of the reporter gene in transgenic embryos was observed during midgestation in anterior midline structures of the developing central nervous system and in the neuroretina. During that period, reporter gene expression appeared within the notochord and floor plate along the entire spinal cord reaching into the caudal diencephalon. In addition, transgene expression was observed in axonal projections emanating from retinal ganglion cells forming the optic nerve to reach the future region of the optic chiasm. Analysis of expression of CD155 during human embryonic development confirmed the distribution of reporter gene expression specified by CD155 promoter activity. The anatomical distribution of CD155 promoter activity during embryogenesis matches that of transacting factors previously identified to regulate transcription of the CD155 gene. Expression of CD155 within embryonic structures giving rise to spinal cord anterior horn motor neurons may explain the restrictive host cell tropism of poliovirus for this cellular compartment of the CNS. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10915595     DOI: 10.1006/viro.2000.0418

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  20 in total

1.  Picornaviruses.

Authors:  Tobias J Tuthill; Elisabetta Groppelli; James M Hogle; David J Rowlands
Journal:  Curr Top Microbiol Immunol       Date:  2010       Impact factor: 4.291

2.  Classification and structure of echovirus 5'-UTR sequences.

Authors:  Nikolaos Siafakas; Dimitrios Papaventsis; Stamatina Levidiotou-Stefanou; Nicholas C Vamvakopoulos; Panayotis Markoulatos
Journal:  Virus Genes       Date:  2005-12       Impact factor: 2.332

Review 3.  Preparing an oncolytic poliovirus recombinant for clinical application against glioblastoma multiforme.

Authors:  Christian Goetz; Matthias Gromeier
Journal:  Cytokine Growth Factor Rev       Date:  2010-03-17       Impact factor: 7.638

4.  The double-stranded RNA binding protein 76:NF45 heterodimer inhibits translation initiation at the rhinovirus type 2 internal ribosome entry site.

Authors:  Melinda K Merrill; Matthias Gromeier
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

5.  Oncolytic poliovirus against malignant glioma.

Authors:  Christian Goetz; Elena Dobrikova; Mayya Shveygert; Mikhail Dobrikov; Matthias Gromeier
Journal:  Future Virol       Date:  2011-09       Impact factor: 1.831

6.  Poliovirus-induced apoptosis is reduced in cells expressing a mutant CD155 selected during persistent poliovirus infection in neuroblastoma cells.

Authors:  Anne-Sophie Gosselin; Yannick Simonin; Florence Guivel-Benhassine; Vincent Rincheval; Jean-Luc Vayssière; Bernard Mignotte; Florence Colbère-Garapin; Thérèse Couderc; Bruno Blondel
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

Review 7.  Targeting PVR (CD155) and its receptors in anti-tumor therapy.

Authors:  Paola Kučan Brlić; Tihana Lenac Roviš; Guy Cinamon; Pini Tsukerman; Ofer Mandelboim; Stipan Jonjić
Journal:  Cell Mol Immunol       Date:  2018-10-01       Impact factor: 11.530

Review 8.  Oncolytic polio virotherapy of cancer.

Authors:  Michael C Brown; Elena Y Dobrikova; Mikhail I Dobrikov; Ross W Walton; Sarah L Gemberling; Smita K Nair; Annick Desjardins; John H Sampson; Henry S Friedman; Allan H Friedman; Douglas S Tyler; Darell D Bigner; Matthias Gromeier
Journal:  Cancer       Date:  2014-06-17       Impact factor: 6.860

9.  Cell-type-specific repression of internal ribosome entry site activity by double-stranded RNA-binding protein 76.

Authors:  Melinda K Merrill; Elena Y Dobrikova; Matthias Gromeier
Journal:  J Virol       Date:  2006-04       Impact factor: 5.103

10.  Poliovirus receptor CD155-targeted oncolysis of glioma.

Authors:  Melinda K Merrill; Guenter Bernhardt; John H Sampson; Carol J Wikstrand; Darell D Bigner; Matthias Gromeier
Journal:  Neuro Oncol       Date:  2004-07       Impact factor: 12.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.